These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10940692)

  • 1. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors.
    Ruszniewski P; Malka D
    Digestion; 2000; 62 Suppl 1():79-83. PubMed ID: 10940692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study.
    Maire F; Lombard-Bohas C; O'Toole D; Vullierme MP; Rebours V; Couvelard A; Pelletier AL; Zappa M; Pilleul F; Hentic O; Hammel P; Ruszniewski P
    Neuroendocrinology; 2012; 96(4):294-300. PubMed ID: 22507901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumours.
    Dominguez S; Denys A; Menu Y; Ruszniewski P
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S213-5. PubMed ID: 10604133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablative therapies for liver metastases of digestive endocrine tumours.
    O'Toole D; Maire F; Ruszniewski P
    Endocr Relat Cancer; 2003 Dec; 10(4):463-8. PubMed ID: 14713259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
    Gupta S; Yao JC; Ahrar K; Wallace MJ; Morello FA; Madoff DC; Murthy R; Hicks ME; Ajani JA
    Cancer J; 2003; 9(4):261-7. PubMed ID: 12967136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours.
    Dominguez S; Denys A; Madeira I; Hammel P; Vilgrain V; Menu Y; Bernades P; Ruszniewski P
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):151-7. PubMed ID: 10741928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.
    Fiorentini G; Rossi S; Bonechi F; Vaira M; De Simone M; Dentico P; Bernardeschi P; Cantore M; Guadagni S
    J Chemother; 2004 Jun; 16(3):293-7. PubMed ID: 15330328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
    Strosberg JR; Choi J; Cantor AB; Kvols LK
    Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors.
    Drougas JG; Anthony LB; Blair TK; Lopez RR; Wright JK; Chapman WC; Webb L; Mazer M; Meranze S; Pinson CW
    Am J Surg; 1998 May; 175(5):408-12. PubMed ID: 9600289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.
    Skinazi F; Zins M; Menu Y; Bernades P; Ruszniewski P
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):673-8. PubMed ID: 8853257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
    Clouse ME; Perry L; Stuart K; Stokes KR
    Digestion; 1994; 55 Suppl 3():92-7. PubMed ID: 7698544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
    Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
    AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.
    Ruszniewski P; O'Toole D
    Neuroendocrinology; 2004; 80 Suppl 1():74-8. PubMed ID: 15477722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.
    Gaur SK; Friese JL; Sadow CA; Ayyagari R; Binkert CA; Schenker MP; Kulke M; Baum R
    Cardiovasc Intervent Radiol; 2011 Jun; 34(3):566-72. PubMed ID: 21431978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study.
    Walter T; Lepage C; Coriat R; Barbier E; Cadiot G; Caroli-Bosc FX; Aparicio T; Bouhier-Leporrier K; Hentic-Dhome O; Gay F; Dupont-Gossart AC; Duluc M; Lepere C; Lecomte T; Smith D; Petorin C; Di-Fiore F; Ghiringhelli F; Legoux JL; Guimbaud R; Baudin E; Lombard-Bohas C; de Baère T;
    Eur J Cancer; 2019 Dec; 123():92-100. PubMed ID: 31678771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours.
    O'Toole D; Ruszniewski P
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):585-94. PubMed ID: 16183529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.
    Ruszniewski P; Rougier P; Roche A; Legmann P; Sibert A; Hochlaf S; Ychou M; Mignon M
    Cancer; 1993 Apr; 71(8):2624-30. PubMed ID: 8384072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients.
    Dong XD; Carr BI
    Med Oncol; 2011 Dec; 28 Suppl 1():S286-90. PubMed ID: 21107755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors.
    Desai DC; O'Dorisio TM; Schirmer WJ; Jung SS; Khabiri H; Villanueva V; Martin EW
    Regul Pept; 2001 Jan; 96(3):113-7. PubMed ID: 11111016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.